TNFAIP3 and myocarditis: In 2015, Gui et al., found that astragaloside IV inhibits NF-κB signaling by increasing A20 (TNFAIP3) expression, leading to the alleviation of cardiac inflammation in coxsackievirus-B3-induced myocarditis [32].